Raymond C. Lamy, MS
Mr. Lamy has over twenty-five years of combined pharmaceutical/biotech industry experience in Regulatory Affairs, Clinical Statistical Programming, and Nonclinical Research, focusing on the development and marketing registration of prescription drug/biotechnology products in several therapeutic areas (i.e., oncology, CNS, pain management, anti-infective). Additional experience with nutritional supplements (“nutriceuticals”), OTC monograph products (antifungals and digestive aids), biologics (blood plasma derivatives, human growth hormone), and medical devices (drug delivery).
Mr. Lamy has extensive knowledge of US FDA regulatory requirements. Submitted and/or managed successful clinical trial applications and new drug applications worldwide. Particularly experienced with the FDA’s CDER, DEA, Orphan Products, and International Affairs divisions; with additional experience with California’s DHS (manufacturing facility and clinical laboratory licenses), CLIA registrations, Health Canada’s TPD, the EMEA, and some Intercontinental/Pacific Rim country health authorities.
Mr. Lamy has assisted with regulatory strategy and issue resolution, competitive product intelligence research, scientific/medical/label writing, SOP development, and determining the viability and commercial potential of products for either acquisition and/or in-house development.